AUT00206

DRUG2 trials

Sponsors

Autifony Therapeutics Limited

Conditions

Schizophrenia

Phase 1

Safety, Blood Levels and Effects of AUT00206

CompletedNCT02589262

Autifony Therapeutics LimitedSchizophrenia

Start: 2015-09-30End: 2016-07-31Updated: 2016-10-14

Safety, Tolerability and Pharmacokinetics of AUT00206 in Patients With Schizophrenia, and Also Explores the Effects of AUT00206 on Relevant Central Biomarkers.

CompletedNCT03164876

Autifony Therapeutics LimitedSchizophrenia

Start: 2017-04-20End: 2019-04-03Updated: 2020-07-31